Uterine manipulator during abdominal hysterectomy and sexual function afterward
Tests a uterine manipulator in hysterectomy for fibroids, looking at later sexual function.
Key facts
- Who runs it
- Erkan Gol
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 2 Mar 2026
- Expected to end
- Feb 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Uterine Manipulator
- Conventional Abdominal Hysterectomy
- Record updated
- 3 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 or older who are planned to have their womb removed through the belly (total abdominal hysterectomy) for a non-cancer reason. It compares surgery with and without a uterine manipulator, a tool that holds and moves the womb.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- A non-cancer condition of the womb, such as fibroids, adenomyoma or abnormal bleeding, with total abdominal hysterectomy planned.
Main reasons for not taking part
- Cancer of the female reproductive organs
- Major extra pelvic repair surgery at the same time
- Severe mental health or nerve system disorder
- Not able to complete follow-up checks
- Not sexually active in the last 4 weeks, or not able to fill in the FSFI sexual function questionnaire
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Women aged ≥18 years
- Planned total abdominal hysterectomy for benign indications
- Sexually active within the last 4 weeks
- Able to complete the Female Sexual Function Index (FSFI) questionnaire
- Provided written informed consent
Who cannot take part
- Major additional pelvic reconstructive surgery
- Gynecologic malignancy
- Severe psychiatric or neurologic disorder
- Inability to complete follow-up assessments
This trial is currently available in Türkiye.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.
The 2 groups in the trial
- Abdominal Hysterectomy With Uterine ManipulatorTreatment being tested
Total abdominal hysterectomy performed using a uterine manipulator.
Treatment: Uterine Manipulator
- Abdominal Hysterectomy Without Uterine ManipulatorExisting treatment, for comparison
Conventional total abdominal hysterectomy performed without uterine manipulator.
Treatment: Conventional Abdominal Hysterectomy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective Randomized Controlled Trial Evaluating the Impact of Uterine Manipulator Use During Total Abdominal Hysterectomy on Postoperative Female Sexual Function
- Plain-language title
- Uterine manipulator during abdominal hysterectomy and sexual function afterwardGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 3 March 2026